Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Contraception news

Show

From To
HIV, family planning groups grapple with new WHO guidance on popular contraceptive

The World Health Organization's reclassification last month of progestogen-only injectable contraceptives has triggered a critical debate in the family planning community over how to manage the potential link between higher rates of HIV acquisition and one of the most popular birth control methods in many at-risk communities.

Published
04 April 2017
From
Devex
Statement by the ECHO Management Committee on the new WHO guidance on use of hormonal contraceptives by women at high risk of HIV

Injectable progestogens are the most widely used contraceptives in sub-Saharan Africa, including in countries with high HIV prevalence. On 2 March 2017, the World Health Organisation (WHO) released revised guidance on the use of hormonal contraceptives by women at high risk of HIV infection.

Published
06 March 2017
From
Evidence for Contraceptive Options and HIV Outcomes (ECHO) Study
Hormonal contraceptive eligibility for women at high risk of HIV: Guidance Statement

The World Health Organization (WHO) convened a technical consultation during 1–2 December 2016 to review new evidence on the risk of HIV acquisition with the use of hormonal contraception. The issue was recognized as a critical one, particularly for sub-Saharan Africa, where women have a high lifetime risk of acquiring HIV, hormonal contraceptives constitute a significant component of the contraceptive method mix and unintended pregnancy is a common threat to the well-being and lives of women and girls.

Published
03 March 2017
From
WHO
Vaginal Ring Form of PrEP Does Not Reduce Contraceptive Effectiveness

The antiretroviral (ARV)-containing vaginal ring form of pre-exposure prophylaxis (PrEP) that reduced HIV risk in a major trial does not lower the effectiveness of hormonal birth control. This finding assuages concerns raised by previous research that the non-nucleoside reverse transcriptase inhibitor (NNRTI) class of ARVs has been associated with a lowered effectiveness of some hormonal contraceptives.

Published
16 February 2017
From
Poz
The Mexico City Policy: An Explainer

On January 23, President Donald Trump reinstated the Mexico City Policy via presidential memorandum. The policy requires foreign non-governmental organizations (NGOs) to certify that they will not “perform or actively promote abortion as a method of family planning,” using funds from any source (including non-U.S. funds), as a condition for receiving U.S. government global family planning assistance and, as of Jan. 23, 2017, any other U.S. global health assistance.

Published
24 January 2017
From
Kaiser Family Foundation
Trump Strikes at Abortion With a Revived Foreign-Aid Rule

The president has reinstated a contentious policy that blocks funding to international family-planning organizations unless they agree not to promote abortion.

Published
23 January 2017
From
The Atlantic
Most contraceptives not linked to HIV infection, but Depo-Provera may raise risk

Birth control pills and some types of injectable and implanted contraceptives were not associated with an increased risk of HIV acquisition in an updated meta-analysis that included

Published
17 August 2016
By
Liz Highleyman
Hormonal contraception and the risk of HIV acquisition in women

The World Health Organization will convene an expert review group later in 2016 to examine the links between the use of various hormonal contraceptive methods and women’s risk of HIV acquisition. The expert review group will assess whether current WHO guidance needs to change in the light of a new review of data, published in AIDS on 9 August 2016, which was commissioned by WHO.

Published
15 August 2016
From
World Health Organization
Sub-Saharan women using modern contraceptives more likely to be HIV tested

Women in sub-Saharan Africa who use modern contraceptives are more likely to be tested for HIV than those who do not, according to a study published April 25, 2016 in the open-access journal PLOS ONE by Katherine Center from the University of Arizona and colleagues.

Published
27 April 2016
From
Eurekalert Inf Dis
An important step toward increasing global access to next-generation female condom

Woman’s Condom achieves WHO/UNFPA prequalification: The Woman’s Condom, a new female condom designed to be easy to use and more acceptable to women and their partners, has been prequalified by the World Health Organization (WHO)/United Nations Population Fund (UNFPA). The approval marks a critical step forward in expanding options for female-initiated dual protection from pregnancy and sexually transmitted infections (STIs), including HIV.

Published
09 March 2016
From
PATH
← First12345...11Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.